<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Phenotyping of <z:chebi fb="1" ids="6030">isoniazid</z:chebi> acetylators in 19 Caucasoid patients with <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> was achieved by evaluating the percentual of <z:chebi fb="0" ids="7207">acetylisoniazid</z:chebi> in the urine </plain></SENT>
<SENT sid="1" pm="."><plain>The proportion of slow acetylators among the patients with <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> was similar to those found among Caucasoids of control group </plain></SENT>
<SENT sid="2" pm="."><plain>The conclusion was that <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> doesn't interfere in the hepatic capacity of <z:chebi fb="1" ids="6030">isoniazid</z:chebi> acetylation </plain></SENT>
</text></document>